Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anti-Estrogen Therapy for Hereditary Hemorrhagic Telangiectasia A Double-Blind Placebo-Controlled Clinical Trial

NCT00375622 is registered in ClinicalTrials.gov with Rabin Medical Center as lead sponsor.

NCT NCT00375622
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00375622 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anti-Estrogen Therapy for Hereditary Hemorrhagic Telangiectasia A Double-Blind Placebo-Controlled Clinical Trial
Lead sponsor
Rabin Medical Center
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2005
Completion date
June 30, 2006
Enrollment
60
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hereditary hemorrhagic telangiectasia